Asia
Ascentage Pharma Presents 17 Clinical Updates at European Hematology Meeting
Ascentage Pharma Group International (HKG:6855) presented 17 clinical updates from core assets at the 31st Congress of the European Hematology Association, including eight poster presentations, according to a Monday Hong Kong bourse filing.The presentations included data from ongoing clinical studies of olverembatinib and lisaftoclax at the conference held in Stockholm, Sweden, from June 11 to June 14.
HKG:6855